Legal & General Group Portfolio holdings
Legal & General Group Plc, founded in 1836 by six lawyers in London, is a British multinational financial services company headquartered in London, renowned for its leadership in insurance, pensions, and investment management. Managing trillions in assets, the firm operates through key divisions like Legal & General Investment Management (LGIM), one of the UK’s largest asset managers, focusing on index funds, active strategies, and sustainable investing for institutional clients like pension funds. It also provides life insurance, retirement products, and general insurance, serving millions of customers with a strong emphasis on long-term financial security and infrastructure investment, such as affordable housing. With a heritage of stability and a modern push toward ESG (environmental, social, governance) principles, Legal & General remains a cornerstone of the UK financial landscape with a growing global presence.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$4.96B |
| 2 |
SUNB
Sunbelt Rentals Holdings
SUNB
|
+$201M |
| 3 |
Palo Alto Networks
PANW
|
+$141M |
| 4 |
Johnson & Johnson
JNJ
|
+$141M |
| 5 |
Rayonier
RYN
|
+$112M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$605M |
| 2 |
Broadcom
AVGO
|
+$425M |
| 3 |
NVIDIA
NVDA
|
+$412M |
| 4 |
Microsoft
MSFT
|
+$347M |
| 5 |
CYBR
CyberArk
CYBR
|
+$238M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.6% |
| 2 | Financials | 12.66% |
| 3 | Healthcare | 10.78% |
| 4 | Communication Services | 9.19% |
| 5 | Consumer Discretionary | 9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2376
Oil-Dri
ODC
$1.43B
| $455K | ﹤0.01% |
6,983
-1,716
| -20% | -$104K |
|
|
CBL
2377
CBL Properties
CBL
$1.78B
| $454K | ﹤0.01% |
11,823
-1,551
| -12% | -$57.5K |
|
|
MIAX
2378
Miami International Holdings
MIAX
$4.14B
| $453K | ﹤0.01% |
11,650
-2,291
| -16% | -$94.4K |
|
2379
UroGen Pharma
URGN
$2B
| $453K | ﹤0.01% |
25,172
+21,529
| +591% | +$432K |
|
|
MANE
2380
Veradermics Inc
MANE
$4.58B
| $449K | ﹤0.01% |
+7,105
| New | +$358K |
|
2381
LSI Industries
LYTS
$853M
| $448K | ﹤0.01% |
24,092
-2,982
| -11% | -$61.5K |
|
2382
Five Star Bancorp
FSBC
$1B
| $447K | ﹤0.01% |
11,857
-5,014
| -30% | -$193K |
|
2383
Global Industrial
GIC
$1.34B
| $447K | ﹤0.01% |
14,189
-3,930
| -22% | -$124K |
|
2384
Sinclair Inc
SBGI
$974M
| $444K | ﹤0.01% |
34,307
-2,423
| -7% | -$35.2K |
|
|
BDN
2385
Brandywine Realty Trust
BDN
$551M
| $444K | ﹤0.01% |
163,656
-270,030
| -62% | -$808K |
|
2386
Annexon
ANNX
$855M
| $443K | ﹤0.01% |
80,046
+70,739
| +760% | +$398K |
|
2387
Great Southern Bancorp
GSBC
$863M
| $443K | ﹤0.01% |
7,019
-1,378
| -16% | -$86.2K |
|
|
CRON
2388
Cronos Group
CRON
$1.05B
| $442K | ﹤0.01% |
175,368
| – | – |
|
2389
Geron
GERN
$911M
| $442K | ﹤0.01% |
296,841
-146,487
| -33% | -$223K |
|
2390
Mission Produce
AVO
$1.1B
| $442K | ﹤0.01% |
32,143
-10,151
| -24% | -$135K |
|
|
BCAX
2391
Bicara Therapeutics
BCAX
$1.78B
| $442K | ﹤0.01% |
22,227
+6,269
| +39% | +$108K |
|
|
GOOS
2392
Canada Goose Holdings
GOOS
$868M
| $442K | ﹤0.01% |
40,373
+3,019
| +8% | +$36.3K |
|
|
RHLD
2393
Resolute Holdings Management
RHLD
$1.09B
| $440K | ﹤0.01% |
2,708
+2,297
| +559% | +$419K |
|
2394
Southern Missouri Bancorp
SMBC
$855M
| $439K | ﹤0.01% |
6,861
-1,959
| -22% | -$123K |
|
2395
Theravance Biopharma
TBPH
$874M
| $437K | ﹤0.01% |
26,928
+22,986
| +583% | +$407K |
|
2396
Heritage Insurance Holdings
HRTG
$842M
| $434K | ﹤0.01% |
16,530
-2,814
| -15% | -$74.3K |
|
2397
American Express Global Business Travel
GBTG
$4.91B
| $433K | ﹤0.01% |
77,653
-28,742
| -27% | -$178K |
|
2398
Rapid7
RPD
$634M
| $430K | ﹤0.01% |
77,995
+1,350
| +2% | +$12.4K |
|
2399
GDS Holdings
GDS
$6.34B
| $429K | ﹤0.01% |
10,658
| – | – |
|
|
ALX
2400
Alexander's
ALX
$1.4B
| $427K | ﹤0.01% |
1,809
-585
| -24% | -$139K |
|
Similar funds
Legal & General Group's Q1 2026 Portfolio in Review
As of Q1 2026, Legal & General Group held 3,422 positions worth $432B, down 4.1% from $451B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Trading was light in Q1 2026: portfolio turnover was 2.7%. Legal & General Group opened 34 new positions and exited 60, leaving the 3,422-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 33% of assets, down from 35% a quarter earlier, followed by Financials and Healthcare.
- Legal & General Group's largest Q1 2026 buy was Sunbelt Rentals Holdings: 2,857,761 shares worth $179M.
- Legal & General Group added most to AstraZeneca in Q1 2026, an estimated $4.96B increase.
- Legal & General Group's biggest Q1 2026 reduction was Apple, cutting an estimated $605M.
- Legal & General Group fully exited CyberArk in Q1 2026, selling an estimated $238M.
- Legal & General Group's ten largest holdings make up 32% of its $432B portfolio in Q1 2026.
- Legal & General Group opened 34 new positions and closed 60 in Q1 2026.
- Legal & General Group's portfolio value fell 4.1% quarter-over-quarter to $432B.
Based on Legal & General Group's 13F filing for Q1 2026, filed 8 May 2026.